Human medicines European public assessment report (EPAR): Trazimera, trastuzumab, Date of authorisation: 26/07/2018, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Trazimera, trastuzumab, Date of authorisation: 26/07/2018, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): GalliaPharm, gallium (68Ga) chloride,germanium (68Ge) chloride, Date of authorisation: 01/08/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): GalliaPharm, gallium (68Ga) chloride,germanium (68Ge) chloride, Date of authorisation: 01/08/2024, Revision: 1, Status: Authorised

15th industry stakeholder platform on research and development support, European Medicines Agency, Amsterdam, the Netherlands, from 4 December 2025, 12:30 (CET) to 4 December 2025, 17:30 (CET)

15th industry stakeholder platform on research and development support, European Medicines Agency, Amsterdam, the Netherlands, from 4 December 2025, 12:30 (CET) to 4 December 2025, 17:30 (CET)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness